SAB Biotherapeutics (SABS) Payables (2020 - 2026)
SAB Biotherapeutics' Payables came in at $7.21 million for Q2 2026, up 1.7% from $7.09 million a year earlier and up 33.8% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, SAB Biotherapeutics' Payables was $6.58 million, up 14.5% from FY2024.
- Payables carries a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
- Going back by year, Payables was $5.75 million in FY2024 (-25.8%), $7.74 million in FY2023 (-27.6%), $10.69 million in FY2022 (-25.0%) and $14.25 million in FY2021 (+79.9%).
- The Q2 2026 figure represents the highest quarterly Payables since Q4 2023.
- Year-over-year, Payables increased in five of the last eight quarters, with growth averaging 2.9%.
- The fastest year-over-year change in Payables over five years came in Q4 2021 (growth of 79.9%), and the weakest in Q3 2023 (a decline of 43.1%).
- Business Quant data shows SABS's Payables at $5.39 million (Q1 2026), $6.58 million (Q4 2025) and $6.85 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.15 Bn | 1,101.73 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 616.41 Bn | 534.94 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 501.01 Bn | 474.12 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 367.15 Bn | 321.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.00 Bn | 261.99 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.56 Bn | 235.25 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.38 Bn | 164.57 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.76 Bn | 116.40 Bn | 10.94 Bn | 7.03 Bn |
| 10 | SAB Biotherapeutics | 232.48 Mn | -185.02 Mn | - | 7.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.21 Mn |
| Mar 31, 2026 | 5.39 Mn |
| Dec 31, 2025 | 6.58 Mn |
| Sep 30, 2025 | 6.85 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Mar 31, 2025 | 6.19 Mn |
| Dec 31, 2024 | 5.75 Mn |
| Sep 30, 2024 | 6.88 Mn |
| Jun 30, 2024 | 5.67 Mn |
| Mar 31, 2024 | 6.01 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Sep 30, 2023 | 5.84 Mn |
| Jun 30, 2023 | 6.04 Mn |
| Mar 31, 2023 | 8.63 Mn |
| Dec 31, 2022 | 10.69 Mn |
| Sep 30, 2022 | 10.26 Mn |
| Jun 30, 2022 | 10.14 Mn |
| Mar 31, 2022 | 12.90 Mn |
| Dec 31, 2021 | 14.25 Mn |
| Dec 31, 2020 | 7.92 Mn |
API Access
SAB Biotherapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();